This inventor holds 1 USPTO granted patent. Top assignee: Karyogene Ab. Active years: 2001.
Company Filing History:
Years Active: 2001
Title: The Innovative Contributions of Mansour Alemi
Introduction
Mansour Alemi is a notable inventor based in Uppsala, Sweden. He has made significant contributions to the field of molecular biology, particularly in cancer research. His work focuses on the identification and characterization of nucleotide sequences that play a crucial role in cancer diagnosis and treatment.
Latest Patents
Mansour Alemi holds a patent for a nucleotide sequence typical for a deletion of the proto-oncogene RET in exon 11. This patent describes an isolated and purified nucleic acid comprising a specific nucleotide sequence, which can be utilized in diagnosing cancer. The information derived from this altered nucleotide sequence can help determine the type and character of tumors, making it a valuable tool in the medical field.
Career Highlights
Alemi is associated with Karyogene AB, where he continues to advance his research in cancer diagnostics. His innovative work has the potential to lead to the development of new reagents and pharmaceutical compositions aimed at preventing and treating cancer.
Collaborations
Throughout his career, Mansour Alemi has collaborated with esteemed colleagues such as Jan Sallström and Erik Wilander. These partnerships have further enhanced his research efforts and contributed to the advancement of cancer diagnostics.
Conclusion
Mansour Alemi's contributions to the field of cancer research through his innovative patent and collaborations highlight the importance of molecular biology in modern medicine. His work continues to pave the way for advancements in cancer diagnosis and treatment.